Co-targeting PIM kinase in drug resistant Non-Small Cell Lung Cancer (Q233284): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Change because item Q2531664 was merged with Q236521) |
(Created claim: summary (P836): Co-cibler la PIM kinase dans le cancer du poumon non à petites cellules résistant aux médicaments, translated_summary) |
||||||||||||||
| Property / summary | |||||||||||||||
Co-cibler la PIM kinase dans le cancer du poumon non à petites cellules résistant aux médicaments (French) | |||||||||||||||
| Property / summary: Co-cibler la PIM kinase dans le cancer du poumon non à petites cellules résistant aux médicaments (French) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: Co-cibler la PIM kinase dans le cancer du poumon non à petites cellules résistant aux médicaments (French) / qualifier | |||||||||||||||
point in time: 25 November 2021
| |||||||||||||||
Revision as of 09:01, 25 November 2021
Project Q233284 in Ireland
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Co-targeting PIM kinase in drug resistant Non-Small Cell Lung Cancer |
Project Q233284 in Ireland |
Statements
16,929.64 Euro
0 references
33,859.27 Euro
0 references
50.0 percent
0 references
1 January 2016
0 references
1 January 2018
0 references
Trinity College Dublin
0 references
Co-targeting PIM kinase in drug resistant Non-Small Cell Lung Cancer (English)
0 references
Co-cibler la PIM kinase dans le cancer du poumon non à petites cellules résistant aux médicaments (French)
25 November 2021
0 references
Identifiers
215
0 references